New British CGM Sava aims to challenge FreeStyle Libre and Dexcom
British startup Sava Technologies is developing a new CGM using microsensors ten times shorter than conventional sensor filaments. Backed by $36 million...
Stories, guides and sensor tips
LIBRE LIFE LATEST NEWS
Articles
-
Latest story
Dexcom Backlash: Agree to our terms or lose access to your glucose readings?
· Samantha Hooper
Dexcom users were furious after being confronted with app Ts&Cs demanding agreement before they could access glucose readings. The backlash over AI, personal data and legal rights has also exposed frustration over sensor accuracy and reliability. What does it mean...
Read article -
-
Adding protein to breakfast could reduce glucose spikes in children with Type 1 diabetes
Could adding an egg or cheese to breakfast help prevent glucose spikes? New UK research involving children and teenagers with type 1...
-
For every £1 Diabetes UK received — Just 6½ p was committed to New Research
Diabetes UK received £43.8 million in 2025, but only 6½p in every £1 was committed to new research from its core funds....
-
What Diabetes UK doesn’t make clear about the £50 Million Fund for a Cure
From Redrow's cladding and fire-safety controversies to Conservative Party donations, discover the billionaire behind the £50 million search for a type 1...
-
Novo Nordisk becomes ‘Novo’ as diabetes giant rebrands for health market
Novo Nordisk is adopting the shorter name ‘Novo’ as part of a major global rebrand. Behind the new logo is a wider...
-
Metformin: Could one of the world’s oldest diabetes drugs slow aging?
Metformin has been used to treat type 2 diabetes for decades. Now researchers are asking whether this familiar drug could also influence...
-
Once-weekly insulin for type 2 diabetes: NICE backs a very different kind of diabetes innovation
NICE has backed once-weekly insulin efsitora alfa, branded Onswik, for type 2 diabetes manangement. It could mean 313 fewer basal injections a...
-
MiniMed Autumn Update: MiniMed Flex launches as Fit patch pump reaches FDA
MiniMed is reshaping its insulin pump range. Flex has launched in the US, while its first tubeless patch pump, MiniMed Fit, has...
-
Coincidence or coordination? Are these buyers investigating Libreband for Abbott?
Abbott employees, a former Eli Lilly scientist, a healthcare lawyer and a university researcher have all appeared around Love My Libre. As...
-
Your CGM has a limit. New research shows how often we reach it
New research analysing almost 47 million CGM readings reveals how often glucose reaches a sensor's measurement limits, how long it can remain...
-
Apple is exploring a screenless health band. We have evidence it was already researching Libreband
Apple is reportedly exploring a screenless health and fitness band that could compete with wearables such as Whoop. Recent events show how...
-
Abbott and Google want your glucose data. But who benefits most?
Abbott and Google plan one of the largest real-world metabolic health studies to date, with consumers buying the sensors and supplying the...
